Zinzino group revenue increased with a total of 32 %, compared with the previous year.

 

The revenue in February for Zinzino's sales markets increased by 32 % and amounted to SEK 281.1 (212.7) million. Faun Pharma's external sales increased and amounted to SEK 5.2 (4.2) million. Overall, the Group increased revenues by 32 % to SEK 286.3 (216.9) million compared with the previous year.

Accumulated revenue for January – February 2026 increased by 26 % to SEK 568.6 (450.8) million.

 

Revenues were distributed as follows:

 

Regions,MSEK	26-Feb	25-Feb	Change	YTD 2026	YTD 2025	Change
The Nordics	22.5	24.8	-9%	50.1	50.5	-1%
Central Europe	81.8	57.4	43%	171.0	126.8	35%
East Europe	26.2	29.0	-10%	55.9	63.2	-12%
South & West Europe	50.2	37.8	33%	97.2	82.0	19%
The Baltics	8.5	8.8	-3%	18.9	19.3	-2%
North America	67.5	32.5	108%	109.9	53.8	104%
South America	3.6	1.2	200%	7.5	2.1	257%
Asia-Pacific	18.6	19.7	-6%	41.7	41.2	1%
Africa	2.2	1.5	47%	4.1	3.0	37%
Zinzino	281.1	212.7	32%	556.3	441.9	26%
Faun Pharma	5.2	4.2	24%	12.3	8.9	38%
Zinzino Group	286.3	216.9	32%	568.6	450.8	26%

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-South America: Peru, Colombia

-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea

-Africa: South Africa

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Pictures for publication free of charge: marketing@zinzino.com

 

Certified Adviser: Tapper Partners AB